Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas J. Jensen

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kobo O, Cavender MA, Jensen TJ, Kuhlman AB, Rasmussen S, Verma S. Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis. Diabetes Obes Metab. 2023 Dec 11. PMID: 38082468.
      View in: PubMed
    2. Kosiborod MN, Verma S, Borlaug BA, Butler J, Davies MJ, Jon Jensen T, Rasmussen S, Erlang Marstrand P, Petrie MC, Shah SJ, Ito H, Schou M, Melenovsk? V, Abhayaratna W, Kitzman DW. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation. 2024 Jan 16; 149(3):204-216. PMID: 37952180.
      View in: PubMed
    3. Andres-Hernando A, Jensen TJ, Kuwabara M, Orlicky DJ, Cicerchi C, Li N, Roncal-Jimenez CA, Garcia GE, Ishimoto T, Maclean PS, Bjornstad P, Sanchez-Lozada LG, Kanbay M, Nakagawa T, Johnson RJ, Lanaspa MA. Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. JCI Insight. 2021 01 11; 6(1). PMID: 33320834.
      View in: PubMed
    4. Crowley MJ, McGuire DK, Alexopoulos AS, Jensen TJ, Rasmussen S, Saevereid HA, Verma S, Buse JB. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. Diabetes Care. 2020 09; 43(9):e108-e110. PMID: 32647053.
      View in: PubMed
    5. Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB. Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial. Diabetes Care. 2018 08; 41(8):1663-1671. PMID: 29898902.
      View in: PubMed
    6. Ahr?n B, Hirsch IB, Pieber TR, Mathieu C, G?mez-Peralta F, Hansen TK, Philotheou A, Birch S, Christiansen E, Jensen TJ, Buse JB. Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial. Diabetes Care. 2016 Oct; 39(10):1693-701. PMID: 27493132.
      View in: PubMed
    7. van den Brink W, Strang J, Gual A, S?rensen P, Jensen TJ, Mann K. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. Expert Opin Drug Saf. 2015 Apr; 14(4):495-504. PMID: 25652768.
      View in: PubMed
    8. Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Under-reporting of adverse effects of tesofensine. Lancet. 2013 Jul 13; 382(9887):127. PMID: 23849924.
      View in: PubMed
    9. Verhamme P, Pakola S, Jensen TJ, Berggren K, Sonesson E, Saint-Remy JM, Balchen T, Belmans A, Cahillane G, Stassen JM, Peerlinck K, Glazer S, Jacquemin M. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clin Ther. 2010 Jun; 32(6):1205-20. PMID: 20637972.
      View in: PubMed
    10. Nielsen AL, Larsen TM, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Astrup A. [The effect of tesofensine on body weight and body composition in obese subjects--secondary publication]. Ugeskr Laeger. 2009 Oct 05; 171(41):2974-7. PMID: 19824222.
      View in: PubMed
    11. Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 11 29; 372(9653):1906-1913. PMID: 18950853.
      View in: PubMed
    12. Bloch Thomsen PE, Joergensen RM, Kanters JK, Jensen TJ, Haarbo J, Hagemann A, Vestergaard A, Saermark K. Phase 2 reentry in man. Heart Rhythm. 2005 Aug; 2(8):797-803. PMID: 16051112.
      View in: PubMed
    13. Jensen TJ, Haarbo J, Pehrson SM, Thomsen B. Impact of premature atrial contractions in atrial fibrillation. Pacing Clin Electrophysiol. 2004 Apr; 27(4):447-52. PMID: 15078396.
      View in: PubMed
    14. Jensen TJ, Haarbo J, Pehrson SM, Thomsen PE. Paroxysmal atrial fibrillation: ectopic atrial activity and prevalence of severely symptomatic patients. Pacing Clin Electrophysiol. 2003 Aug; 26(8):1668-74. PMID: 12877698.
      View in: PubMed
    15. Andersen NH, N?rgaard A, Jensen TJ, Ulstrup J. Sequential unfolding of the two-domain protein Pseudomonas stutzeri cytochrome c(4). J Inorg Biochem. 2002 Feb; 88(3-4):316-27. PMID: 11897346.
      View in: PubMed
    16. Hansen CN, Jensen TJ, Borch-Johnsen K. [Dyslipidemia, diabetes and cardiovascular disease]. Ugeskr Laeger. 2000 Aug 14; 162(33):4367-70. PMID: 10962957.
      View in: PubMed
    17. Deckert T, Yokoyama H, Mathiesen ER, R?nn B, Jensen TJ, Feldt-Rasmussen BF, Borch-Johnsen K, Jensen JS. [Microalbuminuria as predictor of atherosclerotic cardiovascular disease in IDDM]. Ugeskr Laeger. 1997 May 12; 159(20):3010-4. PMID: 9190730.
      View in: PubMed
    18. Jensen TJ, Hilsted JC. [Pharmacological prevention of late complications of diabetes]. Ugeskr Laeger. 1996 Apr 22; 158(17):2402-3. PMID: 8685997.
      View in: PubMed
    19. Skovby F, Dyerberg J, Faergeman O, Haghfelt T, Jensen TJ, Leth A, Sigurd B, Stender S, Vittrup MA. [Hyperlipidemia in children]. Ugeskr Laeger. 1993 Mar 15; 155(11):810-4. PMID: 8460436.
      View in: PubMed
    20. Dyerberg J, Stender S, Andersen GE, Faergeman O, Haghfelt T, Hviid T, Jensen TJ, Leth A, Sigurd B, Skovby F. [Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]. Ugeskr Laeger. 1990 May 14; 152(20):1434-7. PMID: 2343500.
      View in: PubMed
    Jensen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)